Aker BioMarine AS Statistics

Total Valuation

Aker BioMarine AS has a market cap or net worth of NOK 5.76 billion. The enterprise value is 7.19 billion.

Market Cap	5.76B
Enterprise Value	7.19B

Important Dates

The next estimated earnings date is Wednesday, February 12, 2025.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	Sep 9, 2024

Share Statistics

Aker BioMarine AS has 87.69 million shares outstanding. The number of shares has decreased by -0.87% in one year.

Current Share Class	n/a
Shares Outstanding	87.69M
Shares Change (YoY)	-0.87%
Shares Change (QoQ)	-9.48%
Owned by Insiders (%)	5.23%
Owned by Institutions (%)	10.50%
Float	11.85M

Valuation Ratios

The trailing PE ratio is 207.98 and the forward PE ratio is 175.54.

PE Ratio	207.98
Forward PE	175.54
PS Ratio	1.62
PB Ratio	2.88
P/TBV Ratio	6.27
P/FCF Ratio	37.47
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.07, with an EV/FCF ratio of 46.74.

EV / Earnings	3.31
EV / Sales	2.04
EV / EBITDA	14.07
EV / EBIT	n/a
EV / FCF	46.74

Financial Position

The company has a current ratio of 3.68, with a Debt / Equity ratio of 0.79.

Current Ratio	3.68
Quick Ratio	1.24
Debt / Equity	0.79
Debt / EBITDA	2.92
Debt / FCF	10.29
Interest Coverage	0.23

Financial Efficiency

Return on equity (ROE) is 0.95% and return on invested capital (ROIC) is 0.52%.

Return on Equity (ROE)	0.95%
Return on Assets (ROA)	0.47%
Return on Capital (ROIC)	0.52%
Revenue Per Employee	9.45M
Profits Per Employee	5.82M
Employee Count	373
Asset Turnover	0.55
Inventory Turnover	1.54

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +54.77% in the last 52 weeks. The beta is 0.88, so Aker BioMarine AS's price volatility has been lower than the market average.

Beta (5Y)	0.88
52-Week Price Change	+54.77%
50-Day Moving Average	55.26
200-Day Moving Average	70.85
Relative Strength Index (RSI)	62.21
Average Volume (20 Days)	62,100

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aker BioMarine AS had revenue of NOK 3.53 billion and earned 2.17 billion in profits. Earnings per share was 25.05.

Revenue	3.53B
Gross Profit	1.15B
Operating Income	48.44M
Pretax Income	-230.61M
Net Income	2.17B
EBITDA	492.81M
EBIT	48.44M
Earnings Per Share (EPS)	25.05

Full Income Statement

Balance Sheet

The company has 156.90 million in cash and 1.58 billion in debt, giving a net cash position of -1.42 billion or -16.25 per share.

Cash & Cash Equivalents	156.90M
Total Debt	1.58B
Net Cash	-1.42B
Net Cash Per Share	-16.25
Equity (Book Value)	2.00B
Book Value Per Share	22.83
Working Capital	1.72B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 546.51 million and capital expenditures -392.77 million, giving a free cash flow of 153.74 million.

Operating Cash Flow	546.51M
Capital Expenditures	-392.77M
Free Cash Flow	153.74M
FCF Per Share	1.75

Full Cash Flow Statement

Margins

Gross margin is 32.53%, with operating and profit margins of 1.37% and 61.59%.

Gross Margin	32.53%
Operating Margin	1.37%
Pretax Margin	-6.54%
Profit Margin	61.59%
EBITDA Margin	13.98%
EBIT Margin	1.37%
FCF Margin	4.36%

Dividends & Yields

Aker BioMarine AS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	180.99%
Buyback Yield	0.87%
Shareholder Yield	0.87%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Aker BioMarine AS has an Altman Z-Score of 1.44. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.44
Piotroski F-Score	n/a